Breakthrough pneumonia, meningitis and bloodstream infection due to Streptococcus pneumoniae during cefixime therapy

Novella Carannante1, Carlo Pallotto1, Mariano Bernardo2

  • 1First Division of Infectious Diseases, Cotugno Hospital, AORN dei Colli , Naples , Italy.

Insights

Cefixime may not effectively treat severe invasive pneumococcal infections. Penicillin susceptibility testing and cefixime Minimum Inhibitory Concentration (MIC) are crucial for guiding treatment of Streptococcus pneumoniae infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Streptococcus pneumoniae is a primary cause of severe infections like meningitis and pneumonia.
  • Invasive pneumococcal diseases (IPDs) pose significant life-threatening risks.

Observation:

  • Three cases of breakthrough severe IPDs (two meningitis, one bloodstream infection) occurred in patients treated with cefixime.
  • Patients had underlying conditions including otitis, sinusitis, and pneumonia.

Findings:

  • Cefixime demonstrated limited efficacy in treating these invasive pneumococcal infections.
  • Penicillin non-susceptibility in S. pneumoniae may correlate with cefixime treatment failure.
  • Cefixime MIC values above 0.5 mg/L were associated with treatment failure.

Implications:

  • Prompt penicillin susceptibility testing is vital for managing S. pneumoniae infections.
  • Measuring cefixime MIC is recommended to predict treatment outcomes.
  • Clinical guidelines may need updates regarding cefixime use for IPDs.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
788
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
783
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
812
Cranial and Spinal Meninges01:19

Cranial and Spinal Meninges

The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
3.7K